The format for delivering infant supplementation recommended at the 1999 Rio de Janeiro workshop was a food-like vehicle that would be a hybrid of a cookie and a tablet. Such a foodlet had never been engineered or manufactured up to that point. An experienced international vitamin supplier (Roche) and a local pharmaceutical company in Lima (Hersil, S.A.) collaborated in the manufacturing and production of this foodlet. They produced the prototype and then went on to produce coded, masked supplies to provide almost 1000 infants in four developing countries with 180 days' worth of foodlets. This paper documents the process.
Introduction
Micronutrient deficiencies are a worldwide problem [1] . Certain population groups are more vulnerable than others, and infants and toddlers are among the most susceptible because of their rapid rates of growth as well as their low-nutrient-density diets and the often poor bioavailability of micronutrients in traditional complementary (weaning) foods [2, 3] . The growth retardation observed in early life in low-income societies may be due to deficiency of one or more essential vitamins or minerals [4] .
The International Workshop on Micronutrient Supplementation throughout the Life Cycle, convened in November 1999 in Rio de Janeiro, Brazil, responded to this problem. The ideas generated at this meeting centered on the dosing of supplemental micronutrients, both in the dosages of nutrients and the delivery vehicles [5] . The meeting participants reached a consensus as to the ideal characteristics for a supplementation vehicle to administer to infants just completing exclusive breast-feeding at 6 months of age and entering the period of complementary feeding. These characteristics are listed in table 1.
The vehicle chosen for the International Research on Infant Supplementation (IRIS I) multicenter intervention was to be a food-like tablet, or "foodLET." All of the foodLETs used in each of the four sites (Peru, Gabriela Lock S17 South Africa, Indonesia, and Vietnam) were produced in Lima, Peru, through a collaboration between Roche and Hersil, SA in that location.
Nutrient levels
The foodLET provided 100% of the daily requirements (1 RDA) for infants and small children of the following nutrients: vitamins A, D, E, C, B 1 , B 2 , B 6 , B 12 , niacin, folic acid, iron, zinc, copper, and iodine. A thorough rationale for this formulation strategy was discussed at the Lima meeting, May 30-June 1, 2001, and is presented elsewhere in these proceedings by Bienz et al. [6] . We formulated the foodLET with suitable overages to compensate for storage loss through the expected shelf life of the product and its use in the tropical environments of Vietnam and Indonesia. Excipients were added to produce the suitable texture and flavor as well as for technical purposes. The formulation of the foodLET for the single RDA, six-days-per-week arm of the IRIS I intervention is shown in table 2.
The IRIS I protocol encompassed four treatment groups. In one of the groups, micronutrients were to be provided once per week in a dose of 2 RDAs. This required the development of an alternate formulation. However, because this was a randomized and doubleblind field trial, the nutrients had to be compacted into a foodLET that was of the same size and weight as the 1-RDA foodLET. Table 3 provides the details on this formulation. All of the B-complex vitamins in these formulations were commercial forms of high solubility.
The fat-soluble vitamins were highly water-dispersible forms. The source of minerals was chosen considering organoleptic and bioavailability issues. The total weight for both the 1-and 2-RDA foodLETs was 2,800 mg with a diameter of 20 mm.
Storage and packing
Packing requirements were rigorous. Because of the relatively soft nature of the foodLET, we chose blister packs as the most suitable method of packaging. This keeps oxygen out of the product and provides adequate physical protection. Figure 1 shows the blister pack used in the IRIS I study, with seven units, one at the point and to be taken first, which was either the 2-RDA dose or its placebo, and the remaining six, which were daily doses of either nutrients or placebos. 
Fulfi lling the foodLET promise
The supplementation aspect of the 1999 workshop in Rio de Janeiro addressed the difficulties in delivering micronutrients to infants and young children due to their difficulty in swallowing tablets or capsules and the instability of liquid syrups. Something closer to the chemical and cultural nature of food was deemed necessary, and the foodLET was the resulting product. By the time workshop participants met again in Lima in 2001, the IRIS field studies in all four sites had been concluded, including more than 1,500 subjectmonths of delivery of foodLET. Through the design emerging from the Rio meeting, two years earlier, we had created a big tablet that was less "hard" than usual, enabling children as young as 6 months old to suck or chew the tablet. In fact, according to the investigators, the foodLET was harder than would have been ideal. At the South African site, the foodLET was actually disintegrated and mixed into porridge [7] .
The nutrients in the foodLET were soluble and water dispersible. Bioavailability studies performed in Rio de Janeiro research laboratories [8] confirmed adequate bioavailability of selected nutrients within the foodLET formulation.
The combination of an acceptable flavor and citric acid reduced the off flavor that minerals sometimes produce. In practice, the foodLET was easy to dose and proved to be stable. The blister pack generally preserved the integrity of the product. Some blister packs contained crushed tablets upon delivery at some sites, but this did not influence the execution of the intervention.
With respect to cost and affordability, one can never really extrapolate from the situation of an intensive and controlled experimental field study what a product would cost and sell for in the real world of public health programs. The seven-unit blister pack in figure 1 is not the one used in the IRIS I trial, but a simpler one modeled for commercial sales. Indeed, protecting a product that is meant to crumble on-but not beforeuse requires investment in special packaging. And, as stated, the minerals used were from compounds of higher solubility and better organoleptic properties, which are more expensive than more common soluble salts. However, if the promise of efficacy of a weekly delivery of a 2-RDA variety is demonstrated, overall program costs will be competitive compared with daily administration of a less well-crafted product.
Conclusion
The foodLET is a flexible product, created in response to an innovative approach to public health nutrition for young children, which grew out of a workshop held in 1999 in Rio de Janeiro [5] . Less than 2 years later, we were able to examine the experience in a follow-up workshop held in Lima, Peru. The first production for the field trial met most of the parameters required by the workshop participants. We know that the composition of a foodLET can be modified according to the proportion of the RDA that is required to be delivered, the required micronutrient composition, and the intake reference to be used. The foodLET has been met with great enthusiasm as a potential format for infant supplementation. At the same time, we continue to refine the ideal dosage and dosing schedule that will be most safe, effective, and cost-efficient for the prevention of multiple-micronutrient malnutrition in young children in poor societies.
